New Treatment For Crohn’s Disease Uses The Patient’s Own Cells

What is Crohn’s Disease?

Inflammatory bowel disease (IBD) is an immune-mediated chronic inflammatory intestinal condition. Ulcerative colitis (UC) and Crohn’s disease (CD) are the two major types of IBD. While UC involves only the colon, Crohn’s disease can affect any segment in the entire digestive tract starting from the esophagus to the anus. CD affects approximately 620,000 people in the UK alone.

The major symptoms of CD are abdominal pain, diarrhea, weight loss, malnutrition, and chronic fatigue. It can also lead to complications such as fistulas and strictures. Treatment is difficult and requires multiple modalities including immunosuppressant medication and steroids. Unlike UC, surgery is not curative for CD.

Crohn’s Disease

Crohn’s Disease

A novel treatment technique for Crohn’s disease

Researchers at the NIHR Guy’s and St Thomas’ Biomedical Research Centre (BRC) have come up with a novel technique to treat Crohn’s disease by modifying the patient’s own cells. As of now, experiments using this technique have proved to be effective in humans as well. Due to the positive experiment results, researchers expect the clinical trials for the technique to begin within the coming six months. The clinical trial is intended to test the safety and efficacy of the treatment.

The research compared the white blood cells of patients with Crohn’s disease to white blood cells from healthy individuals. The white blood cells of Crohn’s patients called regulatory T cells, produced less in comparison to the regulatory T cells from healthy people. The research findings led to the development of a treatment, which involved modification of the patient’s cells to make them behave in a more similar way as healthy cells.

Professor Graham Lord, previously Director of the NIHR Guy’s and St Thomas’ BRC and currently Vice-President and Dean of the Faculty of Biology, Medicine and Health at the University of Manchester is the lead researcher. Graham said: “This is the next frontier in cell therapy, as we’re going beyond treating the symptoms of Crohn’s disease, and trying to reset the immune system to address the condition.

“It’s a real home-grown treatment in the sense that we started with observing cells and tissues donated by patients at Guy’s and St Thomas’, have developed a treatment, and are now starting to undertake trials, all at the Trust. It shows how central patients are to research, helping to create a treatment that might help thousands of more people.”

Innovative treatment techniques have long been studied to treat bowel disorders, however, only a few actually contribute to improving the disease process. Another technique that had been recently used by researchers in China extracted healthy gut bacteria from the stool of healthy individuals and had them rectally or orally introduced into the patient’s digestive tract. Although it improved digestion and nutrition in some patients, it didn’t reduce the inflammation of Crohn’s disease.

Hopefully, this newer technique using modified cells is more of a definite cure than just a temporary symptom reliever for patients with Crohn’s disease.

References

Patients’ own cells could be the key to treating Crohn’s disease

Articles you may like:

Vaccination Rates below 90% Could Paradoxically Promote the Emergence of Resistant Variants

Nightmare Scenario: Could the Current Poorly Implemented Vaccination Campaign Lead to More Deadly SARS-CoV-2 Strains

Diets High in Plant Proteins Protect Women from Dementia, Cardiovascular Disease, and Cancer

Drinking Too Much Coffee Can Reduce Brain Size, and Cause Dementia

A New Cause of Male Infertility Found: Spermatozoa Swimming in Circles

Possible Causes of the Sudden Fall In COVID-19 Infections in the UK and Europe

SARS-CoV-2 Transmissibility: Can You Really Catch COVID-19 through Flatulence (Farts)?

MIT: A Once a Month Contraceptive Pill Could Soon Become Reality

Moderna and Pfizer’s mRNA Vaccines Do Not Make Straight Men Gay

Researchers to Start Testing Male Contraceptive Gel

Gilmore Health News

Coronavirus: The Real and False Side Effects of COVID-19 Vaccines

Guillain-Barré Syndrome Observed after the First Dose of the AstraZeneca Vaccine

Sponsored:

Genf20 Plus: Reviews, Cost, Benefits, Ingredients, Side Effects, and Testimonials

 

FEEDBACK:

Conversation

Want to Stay Informed?

Join the Gilmore Health News Newsletter!

Want to live your best life?

Get the Gilmore Health Weekly newsletter for health tips, wellness updates and more.

By clicking "Subscribe," I agree to the Gilmore Health and . I also agree to receive emails from Gilmore Health and I understand that I may opt out of Gilmore Health subscriptions at any time.